Abstract
Compliance is now considered an out-of-date term as it implies patients’ inability or unwillingness to do what they are told by a learned professional. Compliance, or more so, the lack of compliance, is a negative term that should now be avoided. Concordance suggests the agreement of treatment type and regimen agreed by the health-care provider and the patient and is a positive ideal to be encouraged [1]. Adherence will be positively or negatively affected by the degree of concordance, thus highlighting the need for careful consideration by the health-care provider of the individual needs of each patient and to encourage a holistic approach to patient management [2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
For the purposes of this chapter, the health-care provider denotes anyone involved in the care of patients with skin disease from the general practitioner and the dermatologist to the district and specialist nurses to the nursing assistants and students, to those involved in support groups and provision of patient information leaflets. Thus, when the term health-care provider, doctor or dermatologist is used, it should be taken to encompass all of the different members of this multidisciplinary team.
References
World Health Organisation (2003) Adherence to long-term therapies: evidence for action. ISBN 92-4-154599-2
National Institute for Health and Clinical Excellence. 3 Mar 2008. Medicines concordance (involving patients in decisions about prescribed medicines) http://www.nice.org.uk/guidance/cg76
Thorneloe RJ, Bundy C, Griffiths CEM, Ashcroft DM, Cordingley L (2013) Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol 168(1):20–31
Williams J, Clemens S, Olienikova K, Tarvin K (2003) The skills for life survey. A national needs and impact survey of literacy, numeracy and ICT skills. Department for Education and Skills, London
Dréno B, Thiboutot D, Gollnick H, Finlay AT, Layton A, Leyden JJ, Leutenegger E, Perez M (2010) Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 49(4):448–456
Miyachi Y, Hayashi N, Furukawa F, Akamatsu H, Matsunaga K, Watanabe S, Kawashima M (2011) Acne management in Japan: study of patient adherence. Dermatology (Basel, Switzerland) 223(2):174–181
Tan JK, Balagurusamy M, Fung K et al (2009) Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg 13:204–208
Jones-Caballero M, Pedrosa E, Peñas PF (2008) Self-reported adherence to treatment and quality of life in mild to moderate acne. Dermatology (Basel, Switzerland) 217(4):309–314
Mufleh L, Gonzalez M, Judodihardjo H, Finlay AH (1999) Compliance is high in patients taking oral isotretinoin for acne. Br J Dermatol 55(141):87
Zaghloul SS, Cunliffe WJ, Goodfield MJ (2005) Objective assessment of compliance with treatments in acne. Br J Dermatol 152(5):1015–1021
Tan X, Al-Dabagh A, Davis SA, Lin HC, Balkrishnan R, Chang J, Feldman SR (2013) Medication adherence, healthcare costs and utilization associated with acne drugs in the Medicaid enrolees with acne vulgaris. Am J Clin Dermatol 14(3):243–251
Gellad WF, Grenard JL, Marcum ZA (2011) A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 9(1):11–23
Koch S, Salem W, Levender MM, Feldman SR (2012) Review of the effect of race/ethnicity on medication adherence. J Am Acad Dermatol 66(4):AB61
Sandoval LF, Feldman SR (2013) Biologics in practice: adherence to biologic therapy in psoriasis. Dermatologist 21(2): 30–34
Burkhart PV, Dunbar-Jacob J (2002) Adherence research in the paediatric and adolescent populations: a decade in review. In: Hayman L, Mahon MM, Turner JR (eds) Chronic illness in children: an evidence-based approach. Springer, New York
Ou HT, Feldman SR, Balkrishnan R (2010) Understanding and improving treatment adherence in paediatric patients. Semin Cutan Med Surg 29:137–140, Elsevier Inc
Drotar D, Bonner MS (2009) Influences on adherence to paediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr 30:574–582
McQuaid EL, Kopel SJ, Klein RB et al (1992) Medication adherence in pediatric asthma: reasoning, responsibility, and behaviour. J Pediatr Psychol 11:190–198
Chisolm SS, Taylor SL, Balkrishnan R et al (2008) Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol 59:677–683
Ellis RM, Koch LH, McGuire E, Williams JV (2011) Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 28(3):242–244
Snyder S, Crandell I, Davis SA, Feldman SR (2014) Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol 15(2):87–94
Shea B, Swindon MV, Tanjong Ghogomu E, Orliz Z, Katchamart W, Rader T, Bombadier C, Wells GA, Tugwell P (2013) Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev (5):CD000951
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Blair, R., Gupta, G. (2016). Impact of Demographic and Treatment-Related Factors. In: Davis, S. (eds) Adherence in Dermatology. Adis, Cham. https://doi.org/10.1007/978-3-319-30994-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-30994-1_3
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-30992-7
Online ISBN: 978-3-319-30994-1
eBook Packages: MedicineMedicine (R0)